Sharma, B. ., Nannuru, K. ., Saxena, S. ., Varney, M. ., & Singh, R. . (2019). CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis. International Journal of Molecular Sciences, 20(5). https://doi.org/10.3390/ijms20051237 (Original work published 2019)

Saxena, S. ., Purohit, A. ., Varney, M. ., Hayashi, Y. ., & Singh, R. . (2018). Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells. BMC Cancer, 18(1), 1283. https://doi.org/10.1186/s12885-018-5204-x (Original work published 2018)

Wu, S. ., Saxena, S. ., Varney, M. ., & Singh, R. . CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB. Current Molecular Medicine, 17(6), 436-449. https://doi.org/10.2174/1566524018666171219100158 (Original work published 2017)

Sharma, B. ., Varney, M. ., Saxena, S. ., Wu, L. ., & Singh, R. . (2016). Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells. Cancer Letters, 372(2), 192-200. https://doi.org/10.1016/j.canlet.2015.12.011 (Original work published 2016)

Saxena, S. ., Hayashi, Y. ., Wu, L. ., Awaji, M. ., Atri, P. ., Varney, M. ., … Singh, R. . (2018). Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis. Oncotarget, 9(5), 5931-5943. https://doi.org/10.18632/oncotarget.23644 (Original work published 2018)